1. |
Miguel AI, Henriques F, Azevedo LF, et al. Systematic review of Purtscher's and Purtscher-like retinopathies[J]. Eye (Lond), 2013, 27(1): 1-13. DOI: 10.1038/eye.2012.222.
|
2. |
Sim R, Cheung G, Ting D, et al. Retinal microvascular signs in COVID-19[J]. Br J Ophthalmol, 2022, 106(9): 1308-1312. DOI: 10.1136/bjophthalmol-2020-318236.
|
3. |
Bottini AR, Steinmetz S, Blinder KJ, et al. Purtscher-like retinopathy in a patient with COVID-19[J/OL]. Case Rep Ophthalmol Med, 2021, 2021: 6661541[2021-03-20]. https://europepmc.org/article/MED/33859855. DOI: 10.1155/2021/6661541.
|
4. |
Mbekeani JN, Raval NK, Vo TA, et al. Purtscher-like retinopathy in a patient with COVID-19-associated coagulopathy[J]. Arq Bras Oftalmol, 2022, 85(5): 513-516. DOI: 10.5935/0004-2749.2020-0328.
|
5. |
Pastore MR, Furlanis G, Tognetto D. Bilateral Purtscher-like retinopathy associated with SARS-CoV-2 infection[J/OL]. JAMA Ophthalmol, 2022, 140(2): e214979[2022-02-17]. https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2789254. DOI: 10.1001/jamaophthalmol.2021.4979.
|
6. |
Rahman EZ, Shah P, Ong JE, et al. Purtscher-like retinopathy in a patient with COVID-19 and disseminated intravascular coagulation[J/OL]. Am J Ophthalmol Case Rep, 2021, 24: 101229[2021-11-11]. https://linkinghub.elsevier.com/retrieve/pii/S2451-9936(21)00238-3. DOI: 10.1016/j.ajoc.2021.101229.
|
7. |
Sheth JU, Narayanan R, Goyal J, et al. Retinal vein occlusion in COVID-19: a novel entity[J]. Indian J Ophthalmol, 2020, 68(10): 2291-2293. DOI: 10.4103/ijo.IJO_2380_20.
|
8. |
Acharya S, Diamond M, Anwar S, et al. Unique case of central retinal artery occlusion secondary to COVID-19 disease[J/OL]. IDCases, 2020, 21: e00867[2020-01-18]. https://linkinghub.elsevier.com/retrieve/pii/S2214-2509(20)30175-X. DOI: 10.1016/j.idcr.2020.e00867.
|
9. |
Dinh RH, Tsui E, Matthew S, et al. Acute macular neuroretinopathy and coronavirus disease 2019[J]. Ophthalmol Retina, 2023, 7(2): 198-200. DOI: 10.1016/j.oret.2022.09.005.
|
10. |
Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection[J]. Eye (Lond), 2020, 34(12): 2352-2353. DOI: 10.4103/ijo.IJO_1333_21.
|
11. |
Iovino C, Au A, Ramtohul P, et al. Coincident PAMM and AMN and insights into a common pathophysiology[J]. Am J Ophthalmol, 2022, 236: 136-146. DOI: 10.1016/j.ajo.2021.07.004.
|
12. |
Fu J, Zhou B, Zhang L, et al. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19[J]. Mol Biol Rep, 2020, 47(6): 4383-4392. DOI: 10.1007/s11033-020-05478-4.
|
13. |
Zhou L, Xu Z, Guerra J, et al. Expression of the SARS-CoV-2 receptor ACE2 in human retina and diabetes-implications for retinopathy[J]. Invest Ophthalmol Vis Sci, 2021, 62(7): 6. DOI: 10.1167/iovs.62.7.6.
|
14. |
Atabay C, Kansu T, Nurlu G. Late visual recovery after intravenous methylprednisolone treatment of Purtscher's retinopathy[J]. Ann Ophthalmol, 1993, 25(9): 330-333.
|
15. |
Wang A, Yen M, Liu J. Pathogenesis and neuroprotective treatment in Purtscher's retinopathy[J]. Jpn J Ophthalmol, 1998, 42(4): 318-322. DOI: 10.1016/s0021-5155(98)00015-x.
|
16. |
Agrawal A, McKibbin MA. Purtscher's and Purtscher-like retinopathies: a review[J]. Surv Ophthalmol, 2006, 51(2): 129-136. DOI: 10.1016/j.survophthal.2005.12.003.
|